Vijay Satyanand Pande, Director at BioAge Labs, Inc. (BIOA), bought 438,390 shares at $19.73 ($8.7M) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Open-market purchase of $8.7M BIOA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.73 | 126,793 | $2.5M | 28.9% |
| 2 | $19.73 | 126,793 | $2.5M | 28.9% |
| 3 | $19.73 | 67,096 | $1.3M | 15.3% |
| 4 | $19.73 | 67,096 | $1.3M | 15.3% |
| 5 | $19.90 | 25,306 | $504K | 5.8% |
| 6 | $19.90 | 25,306 |
| $504K |
| 5.8% |
| Total | $19.75 avg | 438,390 | $8.7M | 100% |